Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
about
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analysesAngiotensin receptor blockers: are they related to lung cancer?Angiotensin receptor blockers and risk of prostate cancer among United States veteransRenin-angiotensin system blockade: Its contribution and controversyWhat is good for the circulation also lessens cancer riskRediscovering ACE: novel insights into the many roles of the angiotensin-converting enzymeReview article: the pathophysiological roles of the renin-angiotensin system in the gastrointestinal tractRepurposing of approved cardiovascular drugsLack of an association between angiotensin receptor blocker based therapy and increased risk of cancer: evidence from large observational studiesAngiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research DatabaseRenin-angiotensin system blockade for the risk of cancer and death.A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitorsOn Inference for Kendall's τ within a Longitudinal Data SettingDoes outcome reporting bias "cause" cancer? Risks associated with hidden data on Angiotensin receptor blockers.Long-term use of angiotensin receptor blockers and the risk of cancerA multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2.Nonexperimental comparative effectiveness research using linked healthcare databasesTranscriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatmentSunitinib combined with angiotensin-2 type-1 receptor antagonists induces more necrosis: a murine xenograft model of renal cell carcinoma.GPCRs and cancerEffects of Baicalin on Blood Pressure and Left Ventricular Remodeling in Rats with Renovascular HypertensionUse of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies.Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesisPathophysiologic therapeutic targets in hypertension: a cardiological point of view.Angiotensin II facilitates breast cancer cell migration and metastasisInhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine.Effect of RAAS inhibition on the incidence of cancer and cancer mortality in patients with glomerulonephritis.A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.Clinical utility of valsartan in the treatment of hypertension in children and adolescentsThe comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohortsPreventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicineExamining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohortIndications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular riskA Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer CellsAngiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
P2860
Q24289205-D3ED1F00-E9EA-4BD7-8A8C-825ABCA574ADQ24622669-42D3F04C-819A-4E52-8B63-FE5D30FFAB6BQ24626548-D0AD7B0F-0BA4-4DE4-B7ED-C38E80FB20B7Q26827221-811161CA-5DEF-4BF0-9D4E-76AE1555E5D3Q26859261-F43B9FFE-9024-4DCF-BADD-2C71C71CD2F0Q27004277-32547146-09BD-4A28-BB52-19C9C6A2341EQ27009109-CE1793AB-DAC6-4B99-9B9D-74BE3BFA61E7Q28074453-A8CE9712-9F1E-4DF7-9289-65D815461E90Q28544725-00722C84-E136-4847-AF52-607E2E0FE9B3Q28730234-246D8299-08DC-4060-92F0-6B42C4D0A4A4Q30249043-ACE43998-5D9C-462C-9DCD-ED05D904001FQ30432209-006D8B71-E571-4FF9-9AB0-99C7CA23E586Q30538154-AF583A3D-B6C3-486E-9A71-5B5CAFB1537BQ30576331-303E0632-6069-40EF-9CF7-B5BA93C46E82Q31109379-04E68337-9712-4BE7-9A5D-4B66D463EF87Q33407858-AF03089C-16A1-45C2-B1C3-7CBB68ABDC1EQ33576469-3C2A0659-909B-405C-A1F4-D92219774655Q33610151-0774F99F-73C3-4D0C-8659-8BFBD35EE62AQ33745382-9B8B4C3E-9553-4E52-8034-8B84D33E0991Q33828719-21C3C712-873C-4E9C-8C12-C52B4C625E02Q33834911-E863E058-183F-421A-A4B6-FA98FB8B76AAQ34005101-AEB32FCF-3227-47B9-8C85-AA425BC189E5Q34093100-52C92DA7-C32B-40DF-9D54-8503C804040AQ34125083-0EB110FA-800F-4B03-862C-8706553DA303Q34142036-720D5A1A-8F55-4B58-8381-C4F7F04E72E9Q34247434-164BAE5E-7C79-4753-A7F7-E8CB09A455B1Q34363486-177B7662-4E8A-4A6C-9B75-26202D2E0A52Q34451915-F6213A7F-45A2-497A-B5D1-9BC5C0BD7ADFQ34668757-E8351848-11B5-411A-A127-46FE9C5A291CQ34957546-1A7A8F9A-7608-4202-B55C-553404BBCA80Q35001942-9E73ABA7-B7C0-44B1-A8D8-C394866DD4DFQ35080208-D774080A-12AE-4B39-87C0-CC210278D763Q35089791-648D8B6A-F1AD-4349-9F10-9D7C4104E002Q35093193-E8DBE0D8-3403-4B6B-B71F-8FA26C6272DDQ35120570-104AD3B6-6144-446F-B39B-AC9B3728FD71Q35131970-4A19EC40-D844-4DDE-A337-92D99653D4DAQ35539305-28074F61-A5D9-4816-B5F1-31DDC4F73BC4Q35609097-B01E710E-C354-4B1A-9581-4DD0803CA018Q35665360-B2966154-D779-46A4-8ED6-2A9778635F00Q35681985-7128819C-F0B3-45E7-A8BC-9F53BE39EBBA
P2860
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiotensin-receptor blockade ...... randomised controlled trials.
@ast
Angiotensin-receptor blockade ...... randomised controlled trials.
@en
type
label
Angiotensin-receptor blockade ...... randomised controlled trials.
@ast
Angiotensin-receptor blockade ...... randomised controlled trials.
@en
prefLabel
Angiotensin-receptor blockade ...... randomised controlled trials.
@ast
Angiotensin-receptor blockade ...... randomised controlled trials.
@en
P2093
P2860
P1433
P1476
Angiotensin-receptor blockade ...... randomised controlled trials.
@en
P2093
Daniel I Simon
Douglas Y Rowland
Ilke Sipahi
James C Fang
Sara M Debanne
P2860
P304
P356
10.1016/S1470-2045(10)70106-6
P577
2010-06-11T00:00:00Z